Epithelial-myoepithelial carcinoma of the lung

Add links
Source: Wikipedia, the free encyclopedia.

Epithelial-myoepithelial carcinoma of the lung
Other namesEMECL Adenomyoepithelioma,[1] Myoepithelioma, Epithelial-myoepithelial tumor, Epimyoepithelial carcinoma, Malignant mixed tumor containing epithelial and myoepithelial cells.[2]
SpecialtyOncology

Epithelial-myoepithelial carcinoma of the lung is a very rare

epithelial neoplasm ("carcinoma") arising from lung tissue.[2]

Genetics

The epithelial component in EMECL's typically strongly express

S-100 protein, while the myoepithelial component stains strongly for actin and S-100 protein, and only focally weakly for cytokeratins.[3]

Diagnosis

Microscopically, EMECL features bi-layered glandular or ductular structures consisting of inner

multipolar cells.[4]

The histologic appearance of these tumors varied, but all shared the common feature of a biphasic proliferation of

epithelial (strong cytokeratin-positive; actin and S-100-negative) and myoepithelial (strong actin and S-100 and focal weak cytokeratin-positive) cells with formation of bilayered ductlike structures. The focal resemblance to other salivary gland-type tumors may cause diagnostic difficulties, particularly in small endobronchial biopsies. Although little is known about their biologic potential due to limited follow-up data, these tumors when in the lung clearly have the capacity to infiltrate and metastasize and therefore should be designated as epithelial-myoepithelial carcinoma. At present, it appears that treatment by complete surgical resection with negative margins alone is appropriate and adequate.[3]

Classification

histological variants recognized under the 4th revision of the World Health Organization (WHO) typing system ("WHO-2004"),[2] currently the most widely used lung cancer classification scheme. Because these variants have differing genetic, biological, and clinical properties, including response to treatment, correct classification of lung cancer cases are necessary to assure that lung cancer patients receive optimum management.[2][6][7]

The WHO-2004 scheme groups lung carcinomas into 8 major types:[2]

EMECL is considered a subtype of salivary gland-like carcinoma, tumors so named because their histological appearance and characteristics closely resemble malignant neoplasms arising in the major and minor

salivary glands.[citation needed
]

Staging

EMECL is staged in the same manner as other non-small cell lung carcinomas, based on the TNM (Tumor-Node-Metastasis) staging system.[8]

Treatment

Complete radical

surgical resection is the treatment of choice for EMECL, and in most cases, results in long-term survival or cure.[9][10]

Prognosis

The prognosis of EMECL is relatively good, and considerably better than most other forms of NSCLC. The skull and dura are possible sites for metastasis from pulmonary EMC. The MIB-1 index is a predictive marker of malignant potential.[citation needed]

Incidence

EMECL is extremely rare, with only a handful of cases reported in the literature.[11]

In the lung, two salivary gland-like carcinomas, mucoepidermoid carcinoma and adenoid cystic carcinoma, while extremely uncommon, occur far more often than does EMECL.[2][12]

References

  1. PMID 7611543
    .
  2. ^
    ISBN 92-832-2418-3. Archived from the original
    (PDF) on 23 August 2009. Retrieved 27 March 2010.
  3. ^
    PMID 18973918
    .
  4. PMID 19369010
    .
  5. PMID 2987102
    .
  6. S2CID 52904357
    .
  7. PMID 19672420
    .
  8. PMID 19262443
    .
  9. PMID 20214352
    .
  10. PMID 22629483
    .
  11. PMID 12683896
    .
  12. S2CID 34718856
    .

External links
Retrieved from "https://en.wikipedia.org/w/index.php?title=Epithelial-myoepithelial_carcinoma_of_the_lung&oldid=1179997673"